Rats with electrolytic lesions of the ventromedial hypothalamus (VMX rats) and sham-operated controls (SHAM rats) were injected with streptozotocin (STZ) at a dose of 50 mg/kg 48 h after the lesions were made. VMX rats were significantly more sensitive to STZ in that over 70% died within 6 wk, whereas none of the SHAM rats died. When smaller doses of STZ were given to VMX rats (30-35 mg/kg), a large percentage still died, although the survivors appeared equally as diabetic (in terms of hyperglycemia and hypoinsulinemia) as SHAM rats given a larger dose of STZ. At 25 mg/kg, the surviving VMX rats were more hyperglycemic than matched controls. We suggest that the increased B-cell activity known to occur in VMX animals might be the important factor in the increased sensitivity to STZ observed. We speculate that similar variation in pancreatic B-cell response to an environmental injury may be an important determinant of diabetes susceptibility in man. DIABETES 29:948-951, November 1980.
The enhanced basal and stimulated insulin secretion are apparently due to increased parasympathetic tone, as is the obesity. 7 - 8 This interaction between the VMH and the endocrine pancreas suggests that lesions of the VMH might be expected to alter pancreatic sensitivity to STZ. To test this, we examined the potency of STZ in rats 48 h after lesions of the VMH or sham lesions. Thus, ample time was allowed for the expression of any short-latency pancreatic changes induced by the lesion before the administration of the STZ, but time was not allowed for obesity to develop. We found a significant increase of sensitivity to STZ in rats with lesions of the VMH.
MATERIALS AND METHODS
Subjects were 120-day-old female Wistar rats obtained from the colony maintained by the Department of Psychology of the University of Washington. They were housed in individual hanging steel cages in a room with a 12/12-h light/dark cycle and an ambient temperature of 23°C. Purina rat chow pellets and water were freely available except for brief intervals specified below.
For the surgery, the animals were anesthetized with Equithesin (3.0 ml/kg, intraperitoneally). With the animal held in a stereotaxic apparatus, bilateral electrolytic lesions were placed in the ventromedial area of the hypothalamus by passing 2.0 mA of direct current for 10 s through an epoxylite-insulated steel anode. The electrode tip was lowered to coordinates 0.8 mm lateral to the midsaggital sinus at the level of bregma and 9.1 mm ventral from the brain surface according to the atlas of Pellegrino and Cushman. 9 Rats receiving such lesions are designated VMX rats. In control rats (SHAM rats) the electrode was lowered to a point 1 mm dorsal to the lesion coordinates and no current was applied. All animals were deprived of food for 12-16 h after surgery and then once again given food and water ad libitum.
Streptozotocin was injected into a tail vein of halothaneanesthetized rats 48 h post-surgery. The rats were fasted 1 - 2 h before the injection, STZ was dissolved in 0.05 M citrate buffer (pH 4.5) at a concentration of 50 mg/ml immediately before use. Other concentrations were used in further experiments as indicated below. After the 2 treatments, the animals were maintained in their home cages with food and water ad libitum. Animals that did not die within 6 wk were killed by decapitation at that time. At the time of killing, they had been fasted for 2-4h. Truncal blood was collected and assayed for glucose by the glucose oxidase method, and immunoreactive insulin assayed by a modification of the double antibody method. 10 The brains of the lesioned animals were then removed and fixed with formalin (10%). Lesion placement was determined by examination of 50-/u.m sections stained with cresyl violet.
RESULTS
VMX animals were more susceptible to the diabetogenic effects of STZ at the dose of 50 mg/kg than were SHAM animals. The data on mortality during the 6 wk after the two treatments are presented in Table 1 . Seventy percent (19 out of 27 rats) of the VMX rats died within 6 wk, whereas none of the SHAM rats receiving the same dose of STZ died. The STZ was effective in producing hyperglycemia and hypoinsulinemia in the surviving VMX and SHAM animals. After the administration of STZ, rats in both groups became hyperphagic, polydipsic, and polyuric, and they experienced progressive weight loss. Glucose was evident in the urine as indicated by Diastix (Ames). Glucose and immunoreactive insulin levels at the time of killing for rats surviving 6wk are summarized in Table 2 . The severity of diabetes, as indicated by the hyperglycemia and hypoinsulinemia, was not reliably different for the VMX and SHAM groups receiving STZ. If lesions of the VMH indeed result in enhanced sensitivity to STZ, as suggested by the mortality data, one might expect a difference in the severity of the blood parameters TABLE 2 Mean (± SEM) plasma glucose and immunoreactive insulin levels and 6-wk change of body weight for rats given 50 mg/kg of STZ and their controls in the survivors. Histologic analysis of these animals revealed that of the 8 rats in the VMX + STZ condition that survived, only 2 actually had extensive bilateral destruction of the VMH. It is inferred from this observation that the lack of a complete lesion actually spared these rats and that the mortality rate for VMX rats is actually higher than the 70% reported. Eight rats in which lesions were produced outside the VMH area had no mortality with 50 mg/kg STZ and demonstrated hyperglycemia comparable to controls.
To investigate this phenomenon further, two comparable groups of VMX rats were injected with either 30 or 35 mg/kg of STZ via the tail vein. The experiment was similar in all other respects. The 6-wk mortality rates and the blood glucose and immunoreactive insulin levels of the survivors are summarized in Table 3 . These VMX rats given 30 or 35 mg/kg of STZ had blood parameters comparable to SHAM rats given the higher dose of STZ (50 mg/kg, cf., Table 2 ). The mortality rate for each of the three doses of STZ (30, 35, and 50 mg/kg) was significantly greater (P < 0.05; chisquare) than that of the SHAM group given STZ at a dose of 50 mg/kg. One further group of rats was given lesions of the VMH and then injected with an even higher dose of STZ (65 mg/kg). The only other procedural difference was that the STZ was administered only 4 h after the surgery. None of these animals survived 6 wk. Figure 1 summarizes the incidence of fatality for all doses of STZ used in the VMX rats. Because so many of the VMX rats given STZ died in these experiments, and because the cause of death could not with certainty be attributed to an increased incidence or severity of diabetes caused by the interaction, we administered an even smaller dose of STZ (25 mg/kg) to groups of VMX-lesioned and sham-lesioned rats. Half (3 out of 6) of the VMX died over the subsequent 6 wk in spite of the lower dose. As seen in Figure 2 , the plasma glucose levels of the surviving VMX-STZ rats were significantly higher than those of the sham-operated controls given STZ, and none of these latter rats died. This experiment therefore confirms that rats with VMX lesions are more diabetic, as determined by the degree of hyperglycemia, than animals with sham lesions.
DISCUSSION
The present data suggest that the effective dose of STZ for producing diabetes is greatly reduced in VMX rats relative to SHAM controls. The observed shift of sensitivity occurs within 48 h of the surgery and before a significant change of weight has occurred. In one previous study, it was concluded that animals made obese by having been fed a high fat diet or by receiving a lesion of the VMH have an increased sensitivity to STZ injected on a body-weight basis. 11 In that study, it was difficult to assess whether the sensitivity was truly increased, since different doses of STZ were given to the obese and the control rats. The present experiment lends further support to an actual increase of sensitivity and further suggests that a change of pancreatic function, and not obesity, is responsible. A conclusion based on altered islet functioning may also explain the increase of sensitivity to STZ when mice are made hyperglycemic by an injection of glucose. 12 It now seems clear that VMH lesions cause a major increase of parasympathetic activity to the islets. 3 Such lesions lead to an increase of basal and stimulated insulin secretion that is evident within hours. 13 The increased B-cell activity is apparently mediated by increased cholinergic stimulation of the islet, since it is blocked by vagotomy. 7 -8 A change of sympathetic activity has also been noted after VMH lesions. 6 -14 This might also play a role in the increased islet activity and altered sensitivity of VMH rats given STZ, since it has been reported that the diabetogenic action of STZ is potentiated by the alpha-adrenergic receptor blocker, phentolamine, in the rat.
15 Increased B-cell function mediated via either branch of the autonomic nervous system may, therefore, account for the altered sensitivity to STZ seen in the present experiment, as well as in previous studies. 11 Our findings suggest that susceptibility to injurious factors leading to B-cell destruction in man might also be dependent upon the functional activity of the islet at the time of exposure. If so, the present findings may provide an important clue to a better understanding of the onset of insulin-dependent diabetes. The peak incidence at puberty coincides with a period of known increase in insulin demand. In addition, a recent study of HLA-identical siblings of insulin-dependent diabetics found an increased insulin response to a glucose challenge. 16 It is tempting to speculate that the increased B-cell secretory response in these genetically susceptible children, particularly at the time of the increased insulin demand of puberty, may explain part of the susceptibility to islet injury and the peculiar age distribution of the onset of insulin-dependent juvenile diabetes.
